Table 5.
Antimicrobial tested | GNB isolates, N (%)
|
||||||
---|---|---|---|---|---|---|---|
Escherichia coli | Proteus spp. | Klebsiella pneumoniae | Citrobacter spp. | Pseudomonas aeruginosa | Enterobacter spp. | Total | |
| |||||||
Ampicillin | 7 (77.8) | 3 (100) | 2 (100.0) | 2 (100.0) | — | 1 (100) | 15 (88.2) |
Amikacine | 1 (11.8) | 0 | 0 | 0 | 0 | 0 | 1 (5.6) |
AMC | 8 (88.9) | 2 (66.7) | 2 | 2 | — | 0 | 14 (82.4) |
Ceftriaxone | 3 (33.3) | 0 | 1 | 0 | — | 0 | 4 (35.5) |
Ciprofloxacin | 3 (33.3) | 0 | 1 | 1 | 0 | 0 | 5 (27.8) |
Gentamycin | 2 (22.2) | 0 | 2 | 0 | 1 | 0 | 5 (27.8) |
Nalidixic acid | 6 (66.7) | 0 | 1 | 1 | — | 0 | 8 (57.1) |
Nitrofurantoin | 0 | 0 | 0 | 0 | — | 0 | 0 |
Norfloxacin | 3 (33.3) | 0 | 1 | 1 | — | 0 | 5 (35.7) |
Cefepime | 3 (33.3) | 0 | 1 | 1 | 0 | 0 | 5 (27.8) |
Cefixime | 3 (33.3) | 1 (33.3) | 1 | 1 | — | 0 | 6 (35.3) |
Abbreviations: AMC, amoxicillin/clavulonic acid; GNB, gram-negative bacterial.